atorvastatin has been researched along with Blood Loss, Postoperative in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barbato, R; Barberi, F; Casacalenda, A; Chello, M; Covino, E; Giacinto, O; Lusini, M; Nappi, F; Nenna, A; Petitti, T; Prestipino, F; Pugliese, G; Spadaccio, C | 1 |
| Barbato, R; Barberi, F; Casacalenda, A; Chello, M; Colicchia, C; Di Lorenzo, D; Forte, F; Gaudino, M; Giacinto, O; Greco, SM; Lusini, M; Mastroianni, C; Miano, N; Nappi, F; Nenna, A; Pugliese, G; Satriano, U; Spadaccio, C | 1 |
2 other study(ies) available for atorvastatin and Blood Loss, Postoperative
| Article | Year |
|---|---|
Preoperative atorvastatin reduces bleeding and blood products use in patients undergoing on-pump coronary artery bypass grafting.
Topics: Aged; Aged, 80 and over; Atorvastatin; C-Reactive Protein; Coronary Artery Bypass; Coronary Artery Disease; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Italy; Logistic Models; Male; Middle Aged; Postoperative Complications; Postoperative Hemorrhage; Preoperative Care; Propensity Score; Retrospective Studies | 2017 |
Preoperative atorvastatin reduces bleeding and blood transfusions in patients undergoing elective isolated aortic valve replacement.
Topics: Aged; Anticholesteremic Agents; Aortic Valve; Atorvastatin; Blood Transfusion; Cardiac Surgical Procedures; Elective Surgical Procedures; Female; Heart Valve Diseases; Heart Valve Prosthesis; Humans; Incidence; Italy; Male; Postoperative Hemorrhage; Preoperative Care; Retrospective Studies | 2019 |